Nuvation Bio Files 2025 Annual Report
Ticker: NUVB · Form: ARS · Filed: 2026-04-10T11:25:11-04:00
Sentiment: neutral
Topics: annual-report, sec-filing, pharmaceuticals
TL;DR
Nuvation Bio dropped its 2025 ARS on 4/10/26. Check it for deets.
AI Summary
Nuvation Bio Inc. filed an Annual Report to Security Holders (ARS) on April 10, 2026, for the period ending December 31, 2025. The company, headquartered in New York, NY, is involved in the Pharmaceutical Preparations industry. This filing provides a summary of the company's performance and financial standing for the fiscal year 2025.
Why It Matters
This report provides shareholders with a comprehensive overview of Nuvation Bio's activities and financial health for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing and does not contain new material information that would immediately impact risk.
Key Players & Entities
- Nuvation Bio Inc. (company) — Filer
- 0001811063 (company) — CIK
- 2026-04-10 (date) — Filing Date
- 2025-12-31 (date) — Period of Report
- 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is an Annual Report to Security Holders (ARS) filing.
When was this filing accepted by the SEC?
The filing was accepted on April 10, 2026.
What period does this report cover?
The report covers the period ending December 31, 2025.
What is Nuvation Bio Inc.'s CIK number?
Nuvation Bio Inc.'s CIK number is 0001811063.
What industry is Nuvation Bio Inc. in?
Nuvation Bio Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
From the Filing
EDGAR Filing Documents for 0001140361-26-014159 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form ARS - Annual Report to Security Holders: SEC Accession No. 0001140361-26-014159 Filing Date 2026-04-10 Accepted 2026-04-10 11:25:11 Documents 1 Period of Report 2025-12-31 Effectiveness Date 2026-04-10 Document Format Files Seq Description Document Type Size 1 ARS ny20065562x2_ars.pdf ARS 1880196 Complete submission text file 0001140361-26-014159.txt 2591078 Mailing Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 Business Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 332-208-6102 Nuvation Bio Inc. (Filer) CIK : 0001811063 (see all company filings) EIN. : 850862255 | State of Incorp.: DE | Fiscal Year End: 1231 Type: ARS | Act: 34 | File No.: 001-39351 | Film No.: 26853697 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)